Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

FDA advisory committee votes on carfilzomib NDA

June 21, 2012

Data monitoring committee recommends continued enrollment in Reolysin trial

June 21, 2012

FDA grants orphan drug status to new therapy for AML

June 21, 2012

Pharmacokinetics of pure icaritin investigated in rats

June 21, 2012

Merck KGaA prepares novel protein kinase inhibitors

June 21, 2012

First clinical data disclosed on Genzyme DNA topoisomerase I inhibitor

June 20, 2012

Novelos reports imaging results with [124I]-CLR-1404 in brain cancer

June 20, 2012

Phase III crizotinib study meets endpoint

June 20, 2012

ETS-2101 trial in brain cancer begins enrollment

June 20, 2012

Novartis reports novel CDK9 inhibitors

June 20, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...